Equities
Health CareMedical Equipment and Services
  • Price (MXN)1,893.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-26.34%
  • Beta--
Data delayed at least 20 minutes, as of Jul 27 2022 14:04 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Medtronic plc is a global healthcare technology company. It develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices. Medical Surgical products include patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. Neuroscience products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems. Diabetes products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. The Company also provides PROPEL and SINUVA, which is bioabsorbable, steroid-eluting implants for sinus patients.

  • Revenue in USD (TTM)31.69bn
  • Net income in USD5.04bn
  • Incorporated2014
  • Employees95.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MDT:NYQ since
announced
Transaction
value
Cathworks LtdAnnounced12 Jul 202212 Jul 2022Announced6.58%--
Acutus Medical Inc-Left-Heart Access PortfolioDeal completed27 Apr 202227 Apr 2022Deal completed-11.22%87.00m
Affera IncAnnounced10 Jan 202210 Jan 2022Announced-9.85%--
Triple Jump Israel LtdRumoured17 Oct 202117 Oct 2021Rumoured-25.79%--
Data delayed at least 15 minutes, as of Aug 19 2022 19:31 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.